State of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs
Lung cancer remains a leading cause of cancer-related mortality globally and presents significant challenges in Egypt. In 2023, the first annual meeting of the Thoracic Oncology Multidisciplinary Faculty, organized by the Egyptian Cancer Research Network and the Egyptian Society of Respiratory Neoplasms, was held in Cairo, Egypt. The meeting aimed to address gaps in lung cancer management across Egypt and the broader Middle East and North Africa region. The discussions focused on the challenges posed by NSCLC and SCLC and emphasized the need for enhanced prevention, early detection, and treatment strategies. Key areas of concern include limited access to advanced diagnostics, such as comprehensive genomic profiling, and the underutilization of targeted therapies and immunotherapies, mainly owing to financial barriers. The meeting highlighted the importance of strengthening lung cancer screening programs, improving smoking cessation efforts, and addressing environmental risk factors like air pollution. Furthermore, the event underscored the need for greater research and collaboration, particularly in areas like precision oncology. The conference concluded with strategic recommendations to improve lung cancer prevention, screening, and treatment, aligning Egypt's lung cancer care with global advancements and ensuring equitable access to cutting-edge therapies.
Authors
- Lobna S. Shash (ORCID: https://orcid.org/0000-0002-1501-2691)
- Taghrid Gaafar (ORCID: https://orcid.org/0000-0002-0346-0948)
- Ahmed Magdy Rabea
- Kei Suzuki (ORCID: https://orcid.org/0000-0002-2227-4737)
- Philip C. Mack (ORCID: https://orcid.org/0000-0003-4750-3812)
- Salma Aboelela
- Mervat El Deftar
- Ehab Khalil (ORCID: https://orcid.org/0000-0002-9938-7959)
- Neemat Kassem (ORCID: https://orcid.org/0000-0001-9295-2823)
- Asrar Al Ahmadi
- Janakiraman Subramanian (ORCID: https://orcid.org/0000-0003-0083-9896)
- Manmeet S. Ahluwalia (ORCID: https://orcid.org/0000-0003-3794-9511)
- Hisham Wahba
- Nurul Akmar Said
- Shaheen Islam (ORCID: https://orcid.org/0009-0002-4814-6757)
- Hamed Al Husaini
- Nada Mohsen (ORCID: https://orcid.org/0009-0000-5854-9010)
- Noha Awad (ORCID: https://orcid.org/0000-0001-6805-6033)
- Rana Khaled (ORCID: https://orcid.org/0000-0003-2167-7662)
- Karen Kelly (ORCID: https://orcid.org/0000-0002-2235-6636)
- Mai Sherif
- Hend Elsherbiny
- Nadia I. Zakhary
- Triparna Sen
- Hussein Khaled
- David R. Gandara
- Abdel Rahman El-Shiekh Mohamed
- Dina Shoukry
- Alaa Abdullah ElSadieque
- M.Yasser Alsedfy
- Radwa Marawan
- Nagla Abdel Karim (ORCID: https://orcid.org/0000-0002-8913-793X)
Institutions
- Ain Shams University (EG)
- Prime Minister's Office (BN)
- Cairo University (EG)
- King Faisal Specialist Hospital & Research Centre (SA)
- Augusta University Health (US)
- National Council of Negro Women (US)
- Virginia Cancer Institute (US)
- Academy of Scientific Research and Technology (EG)
- International Association for the Study of Lung Cancer (US)
- Supreme Council Of Health (QA)
- Armed Forces College of Medicine (EG)
- Miami Heart Research Institute (US)
- UC Davis Health (US)
- University of Virginia (US)
- The Ohio State University (US)
- Alexandria University (EG)
- Assiut University (EG)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- JTO Clinical and Research Reports
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1016/j.jtocrr.2024.100776
- Citations
- 5
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- Howard Hughes Medical Institute
- Wellcome Trust
- Ain Shams University
- Cairo University
- National Institutes of Health
- National Cancer Institute, Cairo University
- National Cancer Institute